Drug Index
EPOGEN/PROCRIT
Generic: EPOETIN ALFA
Review priority: STANDARD Marketing status: Prescription
- Route: MULTIDOSE
- Class: General Medications
- Safety profile: routine
- Latest regulatory update: 30 Apr 2024, 12:00 am (UTC)
Structured Monograph
Approval overview EPOGEN/PROCRIT is listed in Drugs@FDA under application 103234 (BLA). Review priority: STANDARD Marketing status: Prescription Active ingredient EPOETIN ALFA Form and strength VIAL; MULTIDOSE - 20,000/ML Sponsor AMGEN Submission history Latest submission status date: 2024-04-30 00:00:00. Submission type: SUPPL.